4-(2,4-Dichlorobenzoyl)piperidine → Trans (4-{2-[4-(2,4-Dichloro-benzoyl)-piperidin-1-yl]-ethyl}-cyclohexyl)-carbamic acid tert-butyl ester
반응식
[C:17]([CH3:18])([CH3:19])([CH3:20])[O:21][C:22]([NH:23][CH:24]1[CH2:25][CH2:26][CH:27]([CH2:30][CH:31]=[O:32])[CH2:28][CH2:29]1)=[O:33].[Cl:1][c:2]1[c:3]([C:9](=[O:10])[CH:11]2[CH2:12][CH2:13][NH:14][CH2:15][CH2:16]2)[cH:4][cH:5][c:6]([Cl:8])[cH:7]1>>[Cl:1][c:2]1[c:3]([C:9](=[O:10])[CH:11]2[CH2:12][CH2:13][N:14]([CH2:31][CH2:30][CH:27]3[CH2:26][CH2:25][CH:24]([NH:23][C:22]([O:21][C:17]([CH3:18])([CH3:19])[CH3:20])=[O:33])[CH2:29][CH2:28]3)[CH2:15][CH2:16]2)[cH:4][cH:5][c:6]([Cl:8])[cH:7]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-62e7b95060fa45e5805bc7ea1d7a74cb
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (8/10)
반응 노트
불러오는 중…